{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T19:59:19Z","timestamp":1792180759526,"version":"4.4.0"},"reference-count":58,"publisher":"Public Library of Science (PLoS)","issue":"3","license":[{"start":{"date-parts":[[2014,3,4]],"date-time":"2014-03-04T00:00:00Z","timestamp":1393891200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0090541","type":"journal-article","created":{"date-parts":[[2014,3,4]],"date-time":"2014-03-04T22:57:54Z","timestamp":1393973874000},"page":"e90541","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":57,"title":["Reduced sTWEAK and Increased sCD163 Levels in HIV-Infected Patients: Modulation by Antiretroviral Treatment, HIV Replication and HCV Co-Infection"],"prefix":"10.1371","volume":"9","author":[{"given":"Luis M.","family":"Beltr\u00e1n","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roc\u00edo","family":"Mu\u00f1oz Hern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebeca S.","family":"de Pablo Bernal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 S.","family":"Garc\u00eda Morillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jes\u00fas","family":"Egido","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel Leal","family":"Noval","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Ferrando-Martinez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis M.","family":"Blanco-Colio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel","family":"Genebat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 R.","family":"Villar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafael","family":"Moreno-Luna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Antonio","family":"Moreno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2014,3,4]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1097\/QAI.0b013e3181e9be6b","article-title":"Serious fatal and nonfatal non-AIDS-defining illnesses in Europe","volume":"55","author":"A Mocroft","year":"2010","journal-title":"J Acquir Immune Defic Syndr"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"e29","DOI":"10.1161\/CIRCULATIONAHA.107.189624","article-title":"Epidemiological evidence for cardiovascular disease in HIV-infected patients and relationship to highly active antiretroviral therapy","volume":"118","author":"JS Currier","year":"2008","journal-title":"Circulation"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"2506","DOI":"10.1210\/jc.2006-2190","article-title":"Increased acute myocardial infarction rates and cardiovascular risk factors among patients with human immunodeficiency virus disease","volume":"92","author":"VA Triant","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1093\/eurheartj\/ehq483","article-title":"Cardiovascular implications from untreated human immunodeficiency virus infection","volume":"32","author":"JV Baker","year":"2011","journal-title":"Eur Heart J"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1056\/NEJMoa062360","article-title":"CD4+ count-guided interruption of antiretroviral treatment","volume":"355","author":"WM El-Sadr","year":"2006","journal-title":"N Engl J Med"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"e36","DOI":"10.1161\/CIRCULATIONAHA.107.189625","article-title":"Effects of HIV infection and antiretroviral therapy on the heart and vasculature","volume":"118","author":"MP Dub\u00e9","year":"2008","journal-title":"Circulation"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1111\/j.1468-1293.2006.00362.x","article-title":"The use of the Framingham equation to predict myocardial infarctions in HIV-infected patients: comparison with observed events in the D:A:D Study","volume":"7","author":"MG Law","year":"2006","journal-title":"HIV Med"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"32401","DOI":"10.1074\/jbc.272.51.32401","article-title":"TWEAK, a new secreted ligand in the tumor necrosis factor family that weakly induces apoptosis","volume":"272","author":"Y Chicheportiche","year":"1997","journal-title":"J Biol Chem"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"3648","DOI":"10.2741\/2341","article-title":"TWEAK and Fn14. New players in the pathogenesis of atherosclerosis","volume":"12","author":"LM Blanco-Colio","year":"2007","journal-title":"Front Biosci"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/S0006-291X(03)01051-9","article-title":"Characterization of murine TWEAK and its receptor (Fn14) by monoclonal antibodies","volume":"306","author":"M Nakayama","year":"2003","journal-title":"Biochem Biophys Res Commun"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1253\/circj.68.396","article-title":"TWEAK can induce pro-inflammatory cytokines and matrix metalloproteinase-9 in macrophages","volume":"68","author":"SH Kim","year":"2004","journal-title":"Circ J"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1161\/ATVBAHA.110.203364","article-title":"Peripheral artery disease is associated with a high CD163\/TWEAK plasma ratio","volume":"30","author":"JA Moreno","year":"2010","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1016\/j.clinbiochem.2009.06.001","article-title":"Circulating sTWEAK improves the prediction of coronary artery disease","volume":"42","author":"Z Jeli\u0107-Ivanovi\u0107","year":"2009","journal-title":"Clin Biochem"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1161\/01.ATV.0000258972.10109.ff","article-title":"Identification of soluble tumor necrosis factor-like weak inducer of apoptosis (sTWEAK) as a possible biomarker of subclinical atherosclerosis","volume":"27","author":"LM Blanco-Colio","year":"2007","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.atherosclerosis.2010.11.009","article-title":"Soluble TWEAK plasma levels predict expansion of human abdominal aortic aneurysms","volume":"214","author":"JL Mart\u00edn-Ventura","year":"2011","journal-title":"Atherosclerosis"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.atherosclerosis.2007.10.022","article-title":"Serum levels of the atherosclerosis biomarker sTWEAK are decreased in type 2 diabetes and end-stage renal disease","volume":"199","author":"S Kralisch","year":"2008","journal-title":"Atherosclerosis"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"110","DOI":"10.2215\/CJN.02790608","article-title":"Additive effects of soluble TWEAK and inflammation on mortality in hemodialysis patients","volume":"4","author":"JJ Carrero","year":"2009","journal-title":"Clin J Am Soc Nephrol"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.5301\/jn.5000245","article-title":"Soluble TWEAK is associated with atherosclerotic burden in patients with chronic kidney disease","volume":"26","author":"JM Valdivielso","year":"2013","journal-title":"J Nephrol"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1093\/eurjhf\/hfp139","article-title":"Decreased soluble TWEAK levels predict an adverse prognosis in patients with chronic stable heart failure","volume":"11","author":"E Chorianopoulos","year":"2009","journal-title":"Eur J Heart Fail"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.atherosclerosis.2010.02.016","article-title":"Soluble TWEAK is markedly upregulated in patients with ST-elevation myocardial infarction and related to an adverse short-term outcome","volume":"211","author":"E Chorianopoulos","year":"2010","journal-title":"Atherosclerosis"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"785","DOI":"10.2215\/CJN.09231010","article-title":"Soluble TWEAK and PTX3 in nondialysis CKD patients: impact on endothelial dysfunction and cardiovascular outcomes","volume":"6","author":"MI Yilmaz","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1016\/j.atherosclerosis.2011.09.016","article-title":"Impact of soluble TWEAK and CD163\/TWEAK ratio on long-term cardiovascular mortality in patients with peripheral arterial disease","volume":"219","author":"G Urbonaviciene","year":"2011","journal-title":"Atherosclerosis"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"8183","DOI":"10.4049\/jimmunol.178.12.8183","article-title":"A previously unrecognized protein-protein interaction between TWEAK and CD163: potential biological implications","volume":"178","author":"LC Bover","year":"2007","journal-title":"J Immunol"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.atherosclerosis.2009.04.033","article-title":"The CD163-expressing macrophages recognize and internalize TWEAK: potential consequences in atherosclerosis","volume":"207","author":"JA Moreno","year":"2009","journal-title":"Atherosclerosis"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1182\/blood.V99.1.378","article-title":"Identification of the hemoglobin scavenger receptor\/CD163 as a natural soluble protein in plasma","volume":"99","author":"HJ M\u00f8ller","year":"2002","journal-title":"Blood"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1002\/cyto.b.20031","article-title":"Human monocyte CD163 expression inversely correlates with soluble CD163 plasma levels","volume":"63","author":"BH Davis","year":"2005","journal-title":"Cytometry B Clin Cytom"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1093\/eurheartj\/ehr123","article-title":"In vitro and in vivo evidence for the role of elastase shedding of CD163 in human atherothrombosis","volume":"33","author":"JA Moreno","year":"2012","journal-title":"Eur Heart J"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.atherosclerosis.2005.05.004","article-title":"The monocytic lineage specific soluble CD163 is a plasma marker of coronary atherosclerosis","volume":"184","author":"LP Aristoteli","year":"2006","journal-title":"Atherosclerosis"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1161\/CIRCRESAHA.107.149435","article-title":"Downregulation of the hemoglobin scavenger receptor in individuals with diabetes and the Hp 2-2 genotype: implications for the response to intraplaque haemorrhage and plaque vulnerability","volume":"101","author":"AP Levy","year":"2007","journal-title":"Circ Res"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1093\/infdis\/jir214","article-title":"Soluble CD163 made by monocyte\/macrophages is a novel marker of HIV activity in early and chronic infection prior to and after anti-retroviral therapy","volume":"204","author":"TH Burdo","year":"2011","journal-title":"J Infect Dis"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1093\/infdis\/jir520","article-title":"Soluble CD163, a novel marker of activated macrophages, is elevated and associated with noncalcified coronary plaque in HIV-infected patients","volume":"204","author":"TH Burdo","year":"2011","journal-title":"J Infect Dis"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1001\/jama.2012.6698","article-title":"Arterial inflammation in patients with HIV","volume":"308","author":"S Subramanian","year":"2012","journal-title":"JAMA"},{"key":"ref33","first-page":"e1","article-title":"[Consensus document of Gesida and Spanish Secretariat for the National Plan on AIDS (SPNS) regarding combined antiretroviral treatment in adults infected by the human immunodeficiency virus (January 2012)]","volume":"30","author":"Sida Panel de expertos de Gesida y Plan Nacional sobre el","year":"2012","journal-title":"Enferm Infecc Microbiol Clin"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1086\/652749","article-title":"Markers of inflammation, coagulation, and renal function are elevated in adults with HIV infection","volume":"201","author":"J Neuhaus","year":"2010","journal-title":"J Infect Dis"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.phrs.2009.07.009","article-title":"Plasma concentrations of the cardiovascular risk factor asymmetric dimethylarginine (ADMA) are increased in patients with HIV-1 infection and correlate with immune activation markers","volume":"60","author":"K Kurz","year":"2009","journal-title":"Pharmacol Res"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1097\/QAI.0b013e31819a292c","article-title":"Plasma levels of VCAM-1, ICAM-1, E-Selectin, and P-Selectin in 99 HIV-positive patients versus 51 HIV-negative healthy controls","volume":"50","author":"L Calza","year":"2009","journal-title":"J Acquir Immune Defic Syndr"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"e203","DOI":"10.1371\/journal.pmed.0050203","article-title":"Inflammatory and coagulation biomarkers and mortality in patients with HIV infection","volume":"5","author":"LH Kuller","year":"2008","journal-title":"PLoS Med"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1097\/QAI.0b013e3181a9992c","article-title":"Association of C-reactive protein and HIV infection with acute myocardial infarction","volume":"51","author":"VA Triant","year":"2009","journal-title":"J Acquir Immune Defic Syndr"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1086\/652750","article-title":"Pretreatment levels of soluble cellular receptors and interleukin-6 are associated with HIV disease progression in subjects treated with highly active antiretroviral therapy","volume":"201","author":"RC Kalayjian","year":"2010","journal-title":"J Infect Dis"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1086\/605578","article-title":"Relationship between inflammatory markers, endothelial activation markers, and carotid intima-media thickness in HIV-infected patients receiving antiretroviral therapy","volume":"49","author":"AC Ross","year":"2009","journal-title":"Clin Infect Dis"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/j.atherosclerosis.2011.03.035","article-title":"Asymmetric dimethylarginine and coronary artery calcium scores are increased in patients infected with human immunodeficiency virus","volume":"217","author":"JJ Jang","year":"2011","journal-title":"Atherosclerosis"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.1161\/ATVBAHA.109.194852","article-title":"Tumor necrosis factor-like weak inducer of apoptosis (TWEAK) enhances vascular and renal damage induced by hyperlipidemic diet in ApoE-knockout mice","volume":"29","author":"B Mu\u00f1oz-Garc\u00eda","year":"2009","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"2044","DOI":"10.1161\/01.STR.0000230648.00027.00","article-title":"Fn14 is upregulated in cytokine-stimulated vascular smooth muscle cells and is expressed in human carotid atherosclerotic plaques: modulation by atorvastatin","volume":"37","author":"B Mu\u00f1oz-Garc\u00eda","year":"2006","journal-title":"Stroke"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1074\/jbc.M111.287656","article-title":"Studies of binding of tumor necrosis factor (TNF)-like weak inducer of apoptosis (TWEAK) to fibroblast growth factor inducible 14 (Fn14)","volume":"287","author":"A Fick","year":"2012","journal-title":"J Biol Chem"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"e19968","DOI":"10.1371\/journal.pone.0019968","article-title":"Differential expression of CD163 on monocyte subsets in healthy and HIV-1 infected individuals","volume":"6","author":"E Tippett","year":"2011","journal-title":"PLoS One"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1097\/QAD.0b013e328351f756","article-title":"HIV infection induces age-related changes to monocytes and innate immune activation in young men that persist despite combination antiretroviral therapy","volume":"26","author":"AC Hearps","year":"2012","journal-title":"AIDS"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1111\/j.1468-1293.2008.00661.x","article-title":"Reduction in circulating markers of endothelial dysfunction in HIV-infected patients during antiretroviral therapy","volume":"10","author":"US Kristoffersen","year":"2009","journal-title":"HIV Med"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1097\/QAD.0b013e328354f4fb","article-title":"Inflammation markers after randomization to abacavir\/lamivudine or tenofovir\/emtricitabine with efavirenz or atazanavir\/ritonavir","volume":"26","author":"GA McComsey","year":"2012","journal-title":"AIDS"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"e83514","DOI":"10.1371\/journal.pone.0083514","article-title":"Dynamics of Immune Reconstitution and Activation Markers in HIV+ Treatment-Na\u00efve Patients Treated with Raltegravir, Tenofovir Disoproxil Fumarate and Emtricitabine","volume":"8","author":"NT Funderburg","year":"2013","journal-title":"PLoS One"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1160\/TH10-04-0233","article-title":"The effect of initiating combined antiretroviral therapy on endothelial cell activation and coagulation markers in South African HIV-infected individuals","volume":"104","author":"E Jong","year":"2010","journal-title":"Thromb Haemost"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1097\/QAI.0b013e318252f99f","article-title":"HIV replication, inflammation, and the effect of starting antiretroviral therapy on plasma asymmetric dimethylarginine, a novel marker of endothelial dysfunction","volume":"60","author":"JV Baker","year":"2012","journal-title":"J Acquir Immune Defic Syndr"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"e55279","DOI":"10.1371\/journal.pone.0055279","article-title":"Age-associated changes in monocyte and innate immune activation markers occur more rapidly in HIV infected women","volume":"8","author":"GE Martin","year":"2013","journal-title":"PLoS One"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1097\/COH.0000000000000020","article-title":"Can early therapy reduce inflammation?","volume":"9","author":"NG Sandler","year":"2014","journal-title":"Curr Opin HIVAIDS"},{"key":"ref54","doi-asserted-by":"crossref","unstructured":"Hsue PY, Scherzer R, Hunt PW, Schnell A, Bolger AF, <etal>et al<\/etal>.. (2012) Carotid Intima-Media Thickness Progression in HIV-Infected Adults Occurs Preferentially at the Carotid Bifurcation and Is Predicted by Inflammation. J Am Heart Assoc pii: jah3-e000422.","DOI":"10.1161\/JAHA.111.000422"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1111\/j.1468-1293.2012.00996.x","article-title":"Relative risk of cardiovascular disease among people living with HIV: a systematic review and meta-analysis","volume":"13","author":"FM Islam","year":"2012","journal-title":"HIV Med"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1161\/01.CIR.104.3.257","article-title":"Use of human immunodeficiency virus-1 protease inhibitors is associated with atherogenic lipoprotein changes and endothelial dysfunction","volume":"104","author":"JH Stein","year":"2001","journal-title":"Circulation"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1086\/649897","article-title":"Risk of myocardial infarction in patients with HIV infection exposed to specific individual antiretroviral drugs from the 3 major drug classes: the data collection on adverse events of anti-HIV drugs (D:A:D) study","volume":"201","author":"SW Worm","year":"2010","journal-title":"J Infect Dis"},{"key":"ref58","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.atherosclerosis.2012.02.027","article-title":"Atherosclerosis risk in HIV-infected patients: the influence of hepatitis C virus co-infection","volume":"222","author":"P Sosner","year":"2012","journal-title":"Atherosclerosis"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0090541","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,24]],"date-time":"2024-05-24T20:06:46Z","timestamp":1716581206000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0090541"}},"subtitle":[],"editor":[{"given":"Clive M.","family":"Gray","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2014,3,4]]},"references-count":58,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2014,3,4]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0090541","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,3,4]]}}}